Biotech company Bright Minds Biosciences surged more than 40% in premarket trading after announcing positive top-line results from a Phase II clinical trial of one of its therapies for patients with drug-resistant absence epilepsy and developmental encephalopathic epilepsy.

Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.